VLDLR and atherosclerosis: We recently reported that inhibiting DNA methylation pharmacologically by 5-aza-2 deoxycytidine (5-aza-dC) ameliorated atherosclerosis in low density lipoprotein receptor knockout (Ldlr−/−) mice (30).